ArticleSurgical endoscopy2026
Laparoscopic common bile duct exploration and primary suture versus ERCP combined with laparoscopic cholecystectomy for choledocholithiasis: a retrospective comparative study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundBoth laparoscopic common bile duct exploration with primary suture (LBEPS) and endoscopic retrograde cholangiopancreatography (ERCP) combined with laparoscopic cholecystectomy (LC) are established approaches for the treatment of concurrent cholecystocholedocholithiasis. While ERCP + LC remains widely utilized, LBEPS offers distinct advantages as a single-stage, minimally invasive procedure with shorter operative time and expedited recovery.
methodsThis retrospective study compared clinical outcomes between patients undergoing LBEPS (n = 226) and those receiving ERCP + LC (n = 144) at our institution from December 2018 to November 2025. Baseline characteristics, perioperative parameters, complications, and follow-up data were analyzed.
resultsComplete stone clearance (100%) was achieved in both groups, with no conversions to open surgery. One postoperative death occurred in the ERCP + LC group (0.69%). Relative to ERCP + LC, LBEPS patients were older, had wider common bile ducts, and presented with a higher prevalence of preoperative acute cholangitis (all P < 0.05), yet exhibited lower baseline AST and ALT levels (P < 0.05). Following baseline adjustment, LBEPS demonstrated significantly superior postoperative recovery of ALT and AST (P < 0.05). ERCP + LC was associated with shorter general anesthesia time, lower postoperative total bilirubin, direct bilirubin, white blood cell count, and neutrophil count, but higher platelet counts and total hospitalization costs (all P < 0.05). Overall complication rates were comparable between groups (8.85% vs. 7.64%, P > 0.05). LBEPS complications predominantly comprised bile leakage and intra-abdominal infection (3.54% each), whereas ERCP + LC was marked by higher rates of acute pancreatitis (4.17%) and intra-abdominal infection (2.78%). During follow-up, no significant differences emerged in stone recurrence (1.33% vs. 1.39%) or cholangitis incidence (0.88% vs. 0.69%), and no bile duct strictures were observed in either cohort.
conclusionBoth LBEPS and ERCP + LC are safe, effective, and confer distinct benefits, achieving equivalent stone clearance and long-term outcomes. Individualized treatment selection should be guided by patient-specific clinical profiles.
Indexed as
Identifiers
42257936What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.